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ABSTRACT

VASCULAR REACTIVITY IN IMMATURE ARTERIALIZED CAPILLARIES

Sara Hellstrom

Peripheral arterial occlusive disease (PAOD) is a globally prevalent
cardiovascular disease in which atherosclerotic plaques narrow arterial lumen diameters
and restrict blood flow to down stream tissues. The impact of these occlusions can be
mitigated by collateral vessels that connect parallel arterial branches and act as natural
bypasses to maintain perfusion. Some patients with PAOD may not have robust collateral
networks to accommodate ischemic tissues in the event of an occlusion and, therefore,
may be more susceptible to hypoxia and tissue necrosis. In animal models that lack
collateral arterioles, capillaries can arterialize and form functional collaterals; however, in
the early stages of development, they do not exhibit functional vasodilation in response to
muscle contraction. We explored the mechanism of impaired functional vasodilation in
arterialized capillaries by testing endothelial-dependent vasodilation (acetylcholine),
endothelial-independent vasodilation (sodium nitroprusside), and endothelial-independent
vasoconstriction (norepinephrine). First, we performed pilot studies to generate doseresponse curves to each of these agents in spinotrapezius arterioles. The optimal
concentration that produced the most robust vascular responses was 10-5 M for all three
agents. In the following study, the spinotrapezius feed artery was ligated in Balb/C mice,
a strain that lacks native collaterals, to stimulate the development of arterialized
capillaries and determine their vascular reactivity. Although vasodilation and
vasoconstriction in arterialized capillaries seven days post-surgery were impaired
compared to terminal arterioles of similar size in unoperated animals, the vessel diameter
changes were still significant. The comparable impairment in both endothelial-dependent
and endothelial-independent vasodilation indicates that vascular smooth muscle cells are
still developing, rearranging, or both, and are not yet fully capable of regulating diameter
in immature arterialized capillaries. Identifying factors that improve the functionality of
smooth muscle cells in the arterialized capillaries may be applied to improve patient
prognosis during ischemic events in vasculature lacking pre-existing collaterals.
Keywords: arteriogenesis, arterialization, ischemia, peripheral arterial occlusive disease,
vasodilation, spinotrapezius
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I. INTRODUCTION
Clinical Relevance
Chronic ischemia—a restriction of bloody supply to tissue—impairs arterial
function in the microcirculation [2]. Specifically, chronic ischemia due to peripheral
arterial occlusive disease (PAOD) impairs vasodilation in the limb skeletal muscles
(Figure 1) [11]. In 2012, approximately 8 million Americans had PAOD, a number that

Figure 1. Atherosclerosis in PAOD, where narrowed and hardened arteries
reduce blood flow to limbs [3].
has been increasing for the past decade. The most common symptom of PAOD is
intermittent claudication, or hypoxic pain during locomotion, which is amplified during
exercise [3]. The ischemic tissues do not receive sufficient oxygen or nutrients, and a
chemical imbalance leads to cramping and discomfort [3]. In PAOD patients, this
discomfort is extreme and prevents any further immediate exercise.
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Once PAOD has been diagnosed, initial treatments include lifestyle modifications
such as cessation of smoking, integration of regular physical activity, and adjustments in
diet. If lifestyle modifications are ineffective, pharmacotherapy with anti-thrombogenic
medications such as aspirin can be administered to prevent thrombus formation on the
atherosclerotic plaque(s). In severe cases, bypass surgery and percutaneous interventions,
including angioplasty, can be used to restore blood flow downstream of the
atherosclerotic plaque as a last resort [3,7]. Unfortunately, not all patients are candidates
for surgery, percutaneous interventions may fail due to restenosis, and current
pharmacotherapy medications often have undesirable side effects. Therefore, developing
alternative methods to restore blood flow to ischemic zones is necessary to improve
PAOD-patient prognosis and treatment.
Previous Work
Stimulating the development of collateral networks is one potential alternative for
restoring blood flow in patients that are not candidates for bypass or percutaneous
interventions. Collateral networks improve patient prognosis by redirecting blood flow in
the event of arterial occlusion. With a collateral, or a vessel connecting two parallel
arterial segments in series, nutrient-rich blood has an alternative path to reach
downstream tissues that would, otherwise, become anoxic [26]. When blood flow is
redirected and shear stresses increase due to the occlusion, collateral vessels enlarge via
arteriogenesis, in which vessels outwardly remodel and incorporate a thicker layer of
smooth muscle cells [9]. Historically, arteriogenesis was only thought to be possible in
pre-existing collateral arterioles, and not all animal strains have robust collateral
networks to support arteriogenesis by this historical definition. The variation in collateral
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density between strains of mice can be extrapolated to humans such that some patients
may be genetically more susceptible to ischemia.
Two strains of mice that exemplify differences in collateral networks are C57BL6
and Balb/C. C57 is a commonly used strain of mouse in research [25] and has a high
density of collaterals, while the Balb/C strain has a lower or nonexistent density of
collaterals, depending on the tissue. In Balb/C mice, however, upstream arterial occlusion
induces outward remodeling on a smaller scale, involving the arterialization of so-called
“collateral capillaries” that anatomically connect two vascular trees. Although they
typically have high resistances that prevent their function as true collaterals, these
capillaries can recruit smooth muscle cells and develop into arterioles [9,30]. The newly
developed arterialized capillaries act as collaterals to reperfuse ischemic tissues;
however, these new vessels are functionally impaired in their early stages [6].
Specifically, functional vasodilation is absent seven days after occlusion of
upstream arteries in the spinotrapezius muscle of murine models [6]. Interestingly, at 21
days post-ligation, these arterialized capillaries regained functionality and demonstrated
normal vasodilation following muscle contraction, even trending towards a greater than
normal response. Regaining vasodilatory capabilities is important because, when it is
impaired, these arterialized capillaries fail to meet the demands of downstream tissue
when metabolism increases, for instance, during locomotion or exercise [4].
Because the impairment is temporary, the initial dysfunction may be attributed to
immaturity of the vascular smooth muscle cells within the outward remodeling phase
[20]. The cause of early impairment in vessel function is unknown: whether it relates to
smooth muscle cell function, endothelial cell function, or both. Understanding
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impairment in microcirculation, specifically in new collateral vessels resulting from
occlusions of PAOD, could provide knowledge to support the development of more
efficacious therapies to mediate and resolve one of the most prevalent health issues in the
world today.
Purpose of Current Study
The purpose of this study was to determine the mechanism of impaired
vasodilation in immature arterialized capillaries. Specifically, we tested the hypothesis
that impaired functional vasodilation can be explained by vascular smooth muscle cell
(VSMC) dysfunction. To test this hypothesis, arterialized capillaries were exposed to
acetylcholine (ACh), sodium nitroprusside (SNP), and norepinephrine (NE) via
superfusion of a physiological salt solution seven days post-ligation. These agents
allowed us to evaluate endothelial-dependent vasodilation via acetylcholine and smooth
muscle-dependent vasodilation via sodium nitroprusside. Endothelial-independent
vasoconstriction via norepinephrine was also evaluated to confirm that the VSMCs were
contractile.
Acetylcholine (ACh) is a neurotransmitter that leads to vasodilation by diffusing
from synaptic clefts into endothelial cells and activating a G-protein coupled receptor
(GPCR) cascade that stimulates endothelial nitric oxide synthase (eNOS) to then produce
NO [14]. NO binds to smooth muscle cell guanylyl cyclase receptors, which increases
cyclic guanosine monophosphate (cGMP) production, thereby activating protein kinase G
(PKG). PKG closes calcium channels, opens potassium channels, and phosphorylates
myosin light chain kinase, decreasing intracellular calcium levels, inducing
hyperpolarization, and inhibiting contraction, respectively. This reduces cross-bridge
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cycling and relaxes the muscle to ultimately achieve vasodilation [14]. Sodium
nitroprusside (SNP) triggers vasodilation by breaking down into nitric oxide (NO) and
other components, relaxing the smooth muscle directly (Figure 2).

Figure 2. Cell signaling for smooth muscle relaxation [24]. Regardless of the initial
stimulus, vascular smooth muscle ultimately vasodilates in response to NO.
Because SNP bypasses the endothelial activation of NO, SNP is considered a smooth
muscle-dependent vasodilator, and ACh is considered an endothelial-dependent
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vasodilator. Norepinephrine is a neurotransmitter that activates alpha-1 adrenergic
receptors on the smooth muscle cells to increase intracellular calcium, increase crossbridge cycling, and constrict the vessel (Figure 3) [14].

Figure 3. Cell signaling for smooth muscle contraction. Increasing intracellular
calcium within the smooth muscle allows for increased cross-bridge cycling.
The adrenergic receptors activate phospholipase C to break phosphatidylinositol 4,5bisphosphate (PIP2) down into inositol trisphosphate (IP3) and diacylglycerol (DAG).
DAG and IP3 increase intracellular calcium directly and by activating phosphokinase C,
respectively.
We exposed murine spinotrapezius muscles to each of the vasoactive agents to
determine which cell type impairs vasodilation in the arterialized capillaries. Equal
responses from both the terminal arterioles in the sham side and arterialized capillaries in
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the ligated side would demonstrate a lack of dysfunction or damage in the corresponding
vessel; however, failure to respond or difficulty responding implies that either one or both
cell types are impaired. We hypothesize that the smooth muscle is immature so that we
expect equal relative impairment in response to ACh and SNP on the ligated side. Once
the contributors to vascular impairment are specified, we may be able to identify factors
to quicken and support the development and maturation of arterialized capillaries. Less
time with dysfunctional collaterals will reduce tissue susceptibility to ischemia, as
perfusion will more effectively meet tissue metabolic demand. As found in different
strains of mice, there may be a distinct variation in human vasculature that affects our
aptitude to respond to ischemia. Individuals with robust collateral networks are better
equipped to redirect blood flow around an occlusion and avoid strokes and myocardial
infarctions [30]. By facilitating efficient development of these collateral networks, we
may improve prognoses of patients with less advantageous vasculature to cope with
diseases like PAOD.
Specific Aims
Specific Aim 1: To assess the reactivity of terminal arterioles in unoperated mice
with a normal density of pre-existing collaterals to determine optimum reagent
concentrations and to anticipate expected responses.
Specific Aim 2: To test the hypothesis that smooth muscle-dependent vasodilation
is impaired in arterialized capillaries at day-7 following spinotrapezius feed artery
ligation.
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II. METHODS
Animal Care and Housing
Male swiss webster and Balb/C mice were housed in microisolator cages within
temperature controlled rooms in the University Vivarium for the duration of the
experiment where 12 hour light and dark cycles were maintained. All mice were provided
with food, water, bedding, a plastic “mouse house,” and a plastic tube. Balb/C mice had
no more than three other cage-mates. These mice were cared for and utilized under the
guidelines specified by the Cal Poly State University SLO Institutional Animal Care and
Use Committee.
Vascular Reactivity with Intravital Microscopy – Dose Response
All equipment that contacted the solutions was rinsed at the end of every
procedure. This equipment included two bubblers, two 60 mL syringes, a flow meter,
small sections of 1/8” tubing, luer connections, and tips. Physiological salt solution (PSS)
was prepared the day of each procedure from stock solution with 131.9 mM NaCl,
4.7 mM KCl, 1.17 mM MgSO4, 2 mM CaCa2, and 18 mM NaHCO3 mixed in a 1 L
volumetric flask with 1 L of ohmic water. The flask was heated and deoxygenated in a
water bath set to 50ºC with 5% CO2-95% N2 bubbled into it. pH was kept at ~7.4 and
checked with a pH meter. The solution was manually transferred to heated 60 mL
syringes as needed to maintain an effluent flow rate of ~2 mL·min-1 and temperature of
~35ºC. ACh, SNP, and NE were diluted from 10-3 Molar stock solutions to 10-5 Molar.
Each mouse was initially anesthetized using 5% isoflurane in oxygen in an
induction chamber. The mice were, then, transferred to a preparation bench with
isoflurane reduced to ~1-3% and maintained at ~3 l·min-1 via nose cone throughout the
preparations and procedure. The hair on the anterior dorsal aspect of each mouse was
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removed with clippers and depilatory cream. Following skin preparations, each mouse
was transferred to a heat pad in the prone position.
Internal temperatures of each anesthetized mouse were kept at 35ºC via heat pad
and rectal thermistor. Following an initial skin incision at the caudal end of the
spinotrapezius, the skin was retracted and connective tissue removed to expose the
muscle. The exposed tissue was continually irrigated with PSS from the heated syringes,
and any area not irrigated by the PSS was covered with plastic wrap to prevent
desiccation and to minimize atmospheric oxygen exchange.
Terminal arterioles in the spinotrapezius were identified on the intravital
microscope and video was captured of the baseline diameters of the terminal arterioles
after a 30 minute stabilization period. Vasodilator and vasoconstrictor agents were
administered via micropipettes and a graduated cylinder to the area through the syringe
and tubing at 10-7, 10-6, 10-5, and 10-4 Molar concentrations, in that order. After each
vasoactive agent was added, a 5-minute waiting period was utilized to allow the vessels
to equilibrate before recording the videos in the final minute of each respective waiting
period. At the end of the experiment, the mouse was euthanized using cervical
dislocation.
Spinotrapezius Lateral Feed Artery Ligation
To stimulate the arterialization of capillaries, the lateral spinotrapezius feed artery
was ligated. Mice were anesthetized and hair was removed as described above.
Buprenorphine analgesic (0.075 mg·kg-1) was subcutaneously administered prior to the
surgery. To prevent corneal desiccation, veterinary ophthalmic ointment was applied to
the eyes of the mice. A skin incision was made above the cranial, lateral edge of the
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spinotrapezius where it meets with the fat pad. Phosphate buffered saline (PBS) was
frequently applied to prevent desiccation. The fat pad cranial and superficial to the
spinotrapezius muscle was blunt dissected to expose the lateral edge. Between the fat pad
that lies deep to the spinotrapezius and the lateral edge of the muscle; the spinotrapezius
artery/vein pair was identified and the artery was isolated and ligated with free strands of
6-0 silk suture. The skin incision was closed with 7-0 polypropylene suture and analgesic
was subcutaneously administered immediately after the surgery to minimize discomfort
as the animal recovered. For two days following the ligation, the mice received oral
buprenorphine (0.01 mg/mL) mixed in with the water.
Vascular Reactivity with Intravital Microscopy
7 days following each ligation surgery the spinotrapezius muscle was re-exposed.
The same superfusion protocol was followed, as described above, but each vasodilator
agent was only administered to the area once at 10-5 concentrations. Terminal arterioles
were analyzed on the sham side and arterialized capillaries were analyzed on the ligated
side.
Imaging and Statistical Analysis
The images/videos were analyzed using AVA software to compare diameters at
the respective time points and concentrations via percent differences, standard deviation,
and standard error. Significance between diameters and percent changes before and after
reactivity and between the sham and ligated sides was rated against a 0.05 p-value using
paired and homoscedastic statistical t-tests.
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III. RESULTS
Average dosage response curves were calculated for each of the three vasoactive
agents in swiss webster strain mice to determine the concentration necessary to elicit a
maximal response: a maximum vasodilation in response to acetylcholine (ACh) and
sodium nitroprusside (SNP), and a maximum vasoconstriction in response to
norepinephrine (NE) (Figure 3).

Figure 4. Superfusion dosage responses in terminal arterioles of unoperated
animals. A) Diameter in microns of Swiss-Webster strain pre and post exposure to 10fold dilutions of ACh (n=7), SNP (n=9), and NE (n=5). B) Diameter in microns of Balb/C
pre and post exposure to 10-fold dilutions of ACh and SNP (n=1).
The diameter responses from both the Swiss-Webster strain (high density of collaterals)
and the Balb/C strain (low density of collaterals) followed a sigmoid curve pattern. The
11

resting diameters and responses at each concentration are comparable between the strains.
Vessels reached a maximal vasodilation or vasoconstriction at 10-5 molar concentration in
response to each vasoactive agent. Only one dosage response was performed for the
Balb/C strain so that statistics could not be evaluated between the Swiss-Webster and
Balb/C diameters.
We utilized 10-5 molar concentrations of each agent to elicit maximal vasodilation
and vasoconstriction responses. To compare reactivity between arterialized capillaries
and terminal arterioles of approximately the same size in unoperated muscles, vascular
reactivity was assessed in the spinotrapezius muscles of mice with ligated and unligated
(sham) feed arteries seven days post-surgery. The muscles were exposed to acetylcholine
and sodium nitroprusside to observe vasodilation responses, and to norepinephrine to
observe vasoconstriction responses. Vessel diameters were measured in terminal
arterioles before and after ACh and SNP application; however, larger arterioles were
measured following norepinephrine application in attempts to measure accurate diameters
during vasoconstriction. Nearly all vessels on the unoperated sides constricted to a point
at which luminal diameter was absent.
ACh (endothelial-dependent) and SNP (endothelial-independent) both
significantly increased vessel diameters in the terminal arterioles of the sham side and
arterialized capillaries in the ligated side to roughly the same degree; however, the
terminal arterioles dilated significantly more than did the arterialized capillaries (Figure
5A,B). NE (endothelial-independent) significantly decreased vessel diameters in the
sham and ligated sides; however, the terminal arterioles constricted significantly more
than did the arterialized capillaries (Figure 5C).
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Figure 5. Superfusion Day 7 - Terminal arterioles on sham and arterialized
capillaries on ligated side. A) Diameters in microns pre and post exposure to 10-5 ACh
(n=7). B) Diameters In microns pre and post exposure to 10-5 SNP (n=7). C) Diameters In
microns pre and post exposure to 10-5 NE (n=6); * indicates p <= .05 using a paired
students t-test
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For the control arterioles, ACh induced a significant vasodilation from rest 8.0±0.8 µm
vs. dilated 14.2±6.4 µm, SNP induced a significant vasodilation from rest 8.1±0.9 µm vs.
dilated 16.4±2.9 µm, and NE induced a significant vasoconstriction from rest 14.9±9.4
µm vs. dilated 0.0±0.0 µm. For the arterialized capillaries, ACh induced a significant
vasodilation from rest 8.6±1.0 µm vs. dilated 10.5±1.7 µm, SNP induced a significant
vasodilation from rest 9.0±1.1 µm vs. dilated 11.0±1.6 µm, and NE induced a
vasoconstrictive trend from rest 9.2±1.2 µm to 8.2±1.0 µm.
When comparing the percent changes in diameter between the sham and ligated
sides after exposure to vasoactive agents, there were significant differences for each
vasoactive agent. The two vasodilators, ACh and SNP, both increased the percent change
diameter in the sham side significantly more than in the ligated side. The percent change
induced by ACh on the sham vs. ligated side was 72.7±23.2% vs. 23.0±4.9%. The
percent change induced by SNP on the sham vs. ligated side was 104.0±10.8% vs.
23.2±5.5%. The vasoconstrictor, NE, significantly decreased the percent change in
diameter in the sham as compared to the ligated side from -100.0±0.0% vs. -10.7±7.8%
(Figure 6).
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Figure 6. Relative vasoreactivity of the arterioles in the spinotrapezius. Percent
changes between the sham and ligated sides in their respective responses to 10-5 M ACh
and SNP in the terminal arterioles, and 10-5 M NE in the arterioles. P =< 0.05 for all
vasoactive agents; n=4.
SNP has a tendency to induce a greater vasodilation than ACh, though not
significantly. Although the vasoactive agents cause significant changes in diameter to the
arterialized capillaries, these changes are significantly less than those in terminal
arterioles.

15

IV. DISCUSSION
Collateral vessels can maintain perfusion in downstream tissues that would,
otherwise, be ischemic in the event of a conduit artery occlusion. These collaterals
respond to increased shear stress by outwardly remodeling and increase blood flow as a
result of that process; however, collaterals can only outwardly remodel if they exist in the
vasculature. The arterialization of collateral capillaries in animals lacking pre-existing
collateral arterioles can compensate enough to re-establish blood flow to an ischemic
vascular tree [6,9]; however, to match blood flow with tissue demand in the reperfused
areas, collaterals and/or arterialized capillaries need to be able to sufficiently vasodilate.
Although the arterialized capillaries acquire smooth muscle cells within seven days
following the spinotrapezius lateral feed artery ligation, functional vasodilation is absent
at this time point [6,7,9]. In this study, we investigated possible causes of this impairment
by observing endothelial cell-dependent and smooth muscle cell-dependent responses of
arterialized capillaries seven days following the ligation of the spinotrapezius feed artery
in mice lacking collaterals. We established a dosage response curve to identify the
optimal concentrations to induce vasodilation and vasoconstriction.
We also found that, although the arterialized capillaries did not respond to
functional vasodilation at seven days post-ligation, they did significantly dilate or
constrict to respective vasoactive agents. This discrepancy can be explained by the fact
that these arterialized capillaries may not yet be a part of the conduction circuit within the
vasculature. In normally functioning arterioles, local signals to dilate or constrict are
conducted across the endothelial cells to change the diameter of upstream arterioles to
effectively increase flow to the initial local stimulus [13]. Capillaries may not naturally
be included in this circuit, or may not have the appropriate directionality to continue a
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signal within the circuit, so it may take longer than seven days for them to fully
arterialize and adapt to it. The vasoactive reagents were a more direct application to the
endothelial and smooth muscle cells within the arterialized capillaries than the electrode
stimulation of the muscles to instigate distinct diameter changes before the arterialized
capillaries develop into part of the conduction circuit.
Both endothelial cells and smooth muscle cells affect the remodeling process of
arterioles. On a smaller scale, we hope to reveal more specifically how they contribute to
the impaired vascular reactivity of the arterialized capillaries. At 7 days post-ligation, the
arterialized capillaries demonstrated significantly less reactivity as compared to the
terminal arterials of the non-ligated “sham” side. The arterialized capillaries dilated less
in response to the vasodilators and constricted less in response to the vasoconstrictors.
Because endothelial-independent vasodilation mechanisms were impaired to the same
degree as endothelial-dependent mechanisms, we can associate at least part of the
dysfunction with smooth muscle cells; however, we do not have sufficient evidence to
associate causation with endothelial cell impairment. Potential causes of impairment
include smooth muscle cell phenotype, mechanoadaptation, ECM remodeling, and lack
of innervation. Mechanoadaptation and ECM remodeling are thought to eventually
increase the reactivity of smooth muscles, at 28 days for example, but may initially
inhibit proper smooth muscle function [6]. The decreased vasoconstriction may also be
explained by a lack of innervation of the arterialized capillaries.
Endothelial Cell Impairment
Endothelial cell impairment may contribute to the impaired vasodilation and
vasoconstriction in the arterialized capillaries; however, testing endothelial impairment
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would require measuring the production of relaxing factors of the endothelial cells.
Because this was not included in the study, we cannot explain the impairment by
dysfunction of the endothelial cells.
Smooth Muscle Cell Phenotype
Mechanoadaptation entails the reorientation of vascular smooth muscle cells to
accommodate a change in flow within a blood vessel. These mechanical changes are
instigated by changes in shear stress, for example, perhaps, when blood supply is
redirected as a result of an occlusion. In cases where pre-existing collateral vessels exist,
blood flow will follow the path of least resistance and travel through the existing
network, around the occlusion (Figure 7). The pre-existing collaterals experience
increased shear stress following the ligation and consequent vasoactive autacoids are
released. These autacoids include growth factors and vasodilators, like endotheliumderived hyperpolarizing factor and prostaglandins, all of which contribute to the function
and structure of vascular smooth muscle cells. [15] The smooth muscle cells have acute
and chronic responses. During acute responses, smooth muscle cells utilize actin and
myosin cross-bridge cycling to perform vasoconstriction; however, calcium sensitization
and actin filament remodeling are also acute processes that can inhibit vasoconstriction
responses. In a longer-term, chronic context, smooth muscle cells have been observed to
physically rearrange. [15]
Smooth muscle cells must be present for mechanoadaptation to occur. Because
capillaries do not naturally have smooth muscle cells, they must develop and/or recruit
the cells for mechanoadaptation to be a potential means of remodeling.
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Figure 7. Blood flow and shear stress shift inducing collateral vessel development.
[10]
Vascular development revolves around the communication between endothelial and
smooth muscle cells in regulating vascular formation, stabilization, remodeling, and
function via factors such as hepatocyte growth factor (HGF) and angiopoietin-1 (Ang1)
19

[17]. Ang1, which regulates genes in ECs, is involved in recruiting the SMCs and
maturing the vasculature, so that the success of the vascular development depends on
paracrine communication with ECs. Vascular development also depends on endocrine
factor processing [17].
It is possible that the development and recruitment of the smooth muscle cells is
contributing to the impairment because the cells are growing and/or adjusting.
Periovascular cells can be recruited from the nearby arterioles or from the immediately
surrounding tissue [22,28]. In any case, the cells will take time to arrange and,
potentially, to further develop into fully functional cells. For example, if the fibroblasts
are developing into SMCs, they may not yet have sufficient levels of actin and myosin to
properly contract or dilate. Thus, the immaturity of the arterialized capillaries would
impair vascular reactivity.
Future work to expand on this research could entail ex-vivo examination of the
arterialized capillaries to determine their precise cellular constituents. Observing vascular
wall components of capillaries before, during, and after the remodeling process would
provide a more clear depiction of how the cells are arranging and changing. Once we
better understand the process, we may be able to stimulate or control it in vivo.
Extracellular Matrix Remodeling
In addition to the rearrangement of smooth muscle cells, the extracellular matrixintegrin-cytoskeletal axis is activated in response to long-term exposure to shear stress. In
this axis, cell-cell and cell-extracellular matrix connections are strengthened to maintain
vascular wall structural integrity; it is also dynamically involved in controlling
vasoreactivity. [15] The responses in the ECM revolve around strengthening and
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stiffening the vascular wall, a remodeling method thought to make constriction and/or
dilation more efficient. [15]
Outward remodeling has previously been observed in preexisting collaterals and
vessels that already have the smooth muscle cells and ECM interactions to begin with.
Smooth muscle cells do not naturally exist in capillaries, as vasoconstriction and
vasodilation are not functions of that vessel type. When the spinotrapezius feed artery is
ligated in a muscle containing few or no collaterals, blood flow redirects through
collateral capillaries that connect arterial branches from other nearby feed vessels to
accommodate the lack of perfusion. These collateral capillaries enlarge, and may remodel
in a similar fashion to the preexisting collaterals. The results from this study point to
early stages of smooth muscle cell maturation as a cause for the impaired vasoreactivity.
The smooth muscle cells are likely immature in development and positioning so that they
are not as receptive and/or responsive to vasoactive agents.
The ability of capillaries to arterialize provides many possibilities for individuals
lacking pre-existing collaterals to reperfuse ischemic tissues in the event of an arterial
occlusion. These developed capillaries provide new bypass routes for blood to travel
around the occlusion and reach areas downstream from the blockage. Further
understanding of the mechanisms of this development may expose specific elements that
are involved; these elements could be exogenously introduced to elicit or quicken the
development process. The sooner blood returns to an ischemic area, the less time the
tissues lack oxygen, nutrients, and the potential for necrosis.
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Lack of Innervation
Capillaries do not naturally have smooth muscle cells or innervation from the
sympathetic nervous system, as dilation and constriction to regulate blood flow are not
capillary functions. Though it can also cause dilation through β-adrenergic receptors,
SNS stimulation typically causes vasoconstriction in skeletal muscle arterioles by
activation of α-adrenergic receptors [27]. While norepinephrine (NE) is a very common
constricting factor, cells may not be sensitive to it if they are not regularly exposed to the
neurotransmitter. The insensitivity to NE could be due to decreased expression of the αadrenergic receptor, a complete lack of innervation, insufficiently organized actin and
myosin preventing effective contractions.
Limitations
One limitation to this study is that dosage response curves were only performed
on one replicate of the Balb/C strain. It is possible that the reactivity of the Balb/C strain
varies enough from that of the Swiss-Webster strain that the concentrations used were not
maximal, on average. The latter instance would have affected the data by resulting in
smaller diameters during vasodilation and larger diameters during vasoconstriction,
effectively reducing the percent change in diameter after exposure to each of the
vasoactive agents. In future studies, dosage response curves could be calculated with
more replicates of the Balb/C strain to confirm the optimal concentrations for NE, SNP,
and ACh.
Another limitation of this study is that other, natural stimuli are not necessarily
accounted for. Sometimes, the vessels are dilated by other factors, such as muscle
twitching, so that the baseline measurements may not reflect true resting values. When
the muscles twitch, the local vessels dilate and vessels in other branches constrict,
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varying the baseline to exaggerate either a difference or a similarity. The effects of
muscle twitching are mitigated by continual irrigation with PSS and covering exposed
tissue with plastic wrap when not in use. However, these measures do not prevent random
muscle twitching and may not eliminate other stimuli. A more developed protocol for
obtaining and monitoring baseline values may allow for more accurate measurements.
For example, more effectively preventing muscle twitching with a different saline
solution or cover, or minimizing the presence of other stimuli with longer equilibration
periods may improve baseline accuracy.
Summary
Vascular reactivity in arterialized capillaries is, at least in part, impaired by
smooth muscle cells, which are presumably immature. This immaturity may lead to
dysfunction because the smooth muscle cells are not yet fully-aligned, may not yet
contain normal levels of actin and myosin, or may express lower levels of vasoactive
receptors. By understanding the mechanisms behind the impairment, we may be able to
minimize the duration and extent of the impairment to more quickly and effectively
increase perfusion to downstream tissues. An extrapolated application of this could
potentially be to induce or quicken the development of new collateral vessels.
Manipulating the arterialization of capillaries may improve PAOD patient prognosis by
more quickly and appropriately providing and improving blood flow to ischemic tissues
downstream of an occlusion.

23

REFERENCES
1.
Berne, Robert M., Matthew N. Levy, Bruce M. Koeppen, and Bruce A.
Stanton. Berne & Levy Physiology. Philadelphia, PA: Mosby/Elsevier, 2008.
Print.
2.

Cardinal, Trevor, and Kyle Struthers. "Chronic Hindlimb Ischemia Impairs
Functional Vasodilation and Vascular Reactivity in Mouse Feed Arteries."
Frontiers in Physiology 2 (2011): 91. Print.

3.

CDC. "Peripheral Arterial Disease (PAD) Fact Sheet." Centers for Disease
Control and Prevention. Centers for Disease Control and Prevention, 23 Feb.
2011. Web. 31 Mar. 2013.

4.

Chalothorn, Dan E. "Strain-dependent Variation in Collateral Circulatory
Function in Mouse Hindlimb." Physiol Genomics 42.3 (2010): 469-79. Print.

5.

Cunha, John P. "Claudication Causes, Symptoms, Diagnosis, and Treatment
by MedicineNet.com." MedicineNet. Ed. William C. Shiel. MedicineNet, 15
July 2011. Web. 31 Mar. 2013.

6.

Cutts, Josh, Feilim MacGabhann, and Trevor Cardinal. "Functional
Vasodilation of Arterilized Capillaries Is Impaired in the Spinotrapezius."
Thesis. California Polytechnic State University San Luis Obispo, n.d. Print.

7.

Feringa, H., V. Vanwaning, J. Bax, A. Elhendy, E. Boersma, O. Schouten, W.
Galal, R. Vidakovic, M. Tangelder, and D. Poldermans. "Cardioprotective
Medication Is Associated With Improved Survival in Patients With Peripheral
Arterial Disease." Journal of the American College of Cardiology 47.6
(2006): 1182-187. Print.

8.

Friederich, Jeffrey A., MD, and John F. Butterworth IV, MD. "Sodium

24

Nitroprusside: Twenty Years and Counting." Anesthesia and Analgesia 81
(1995): 152-62. Print.
9.

Gabhann, Feilim Mac, and Shayn M. Peirce. "Collateral Capillary
Arterialization following Arteriolar Ligation in Murine Skeletal Muscle."
Microcirculation 17 (2010): 1-15. Print.

10.

Gallagher, Ryan. THE IMPACT OF OUTWARD REMODELING ON
VASODILATION IN SKELETAL MUSCLE RESISTANCE ARTERIES. Thesis.
California Polytechnic State University San Luis Obispo, 2012. N.p.: n.p., n.d.
Print.

11.

Gudmundsson, G., S. Matthiasson, H. Arason, H. Johannsson, F. Runarsson,
H. Bjarnason, K. Helgadottir, S. Thorisdottir, G. Ingadottir, and K.
Lindpaintner. "Localization of a Gene for Peripheral Arterial Occlusive
Disease to Chromosome 1p31." The American Journal of Human Genetics
70.3 (2002): 586-92. Print.

12.

Handschin, Christoph, and Bruce M. Spiegelman. "The Role of Exercise and
PGC1α in Inflammation and Chronic Disease." Nature 454.7203 (2008): 46369. Print.

13.

Hill, Caryl E. "Long Distance Conduction of Vasodilation: A Passive or
Regenerative Process?" Microcirculation 19.5 (2012): 379-90. Print.

14.

Hose, Jo. "Cardiovascular Cell Signaling Background." California Polytechnic
State University, San Luis Obispo. 20 Feb. 2013. Reading.

15.

Kellogg, D. L. "Acetylcholine-induced Vasodilation Is Mediated by Nitric
Oxide and Prostaglandins in Human Skin." Journal of Applied Physiology

25

98.2 (2004): 629-32. Print.
16.

Klabunde, Richard E. Cardiovascular Physiology Concepts. Philadelphia:
Lippincott Williams & Wilkins, 2005. Print.

17.

Kobayashi, Hanako, Laura M. DeBusk, Yael O. Babichev, Daniel J. Dumont,
and Pengnian C. Lin. "Hepatocyte Growth Factor Mediates Angiopoietininduced Smooth Muscle Cell Recruitment." Hepatocyte Growth Factor
Mediates Angiopoietin-induced Smooth Muscle Cell Recruitment. The
American Society of Hematology, 25 Apr. 2006. Web. 16 May 2013.

18.

Kumar, Vinay, Abul K. Abbas, Jon C. Aster, and Stanley L. Robbins. Robbins
Basic Pathology. 9th ed. Philadelphia, PA: Elsevier/Saunders, 2013. Print.

19.

Lusis, Aldons J. "Atherosclerosis." Nature 407 (2000): 233-41. Print.

20.

Martinez-Lemus, L. A., M. A. Hill, and G. A. Meininger. "The Plastic Nature
of the Vascular Wall: A Continuum of Remodeling Events Contributing to
Control of Arteriolar Diameter and Structure." Physiology 24.1 (2009): 45-57.
Print.

21.

Moneta, G. "Vascular Surgery for Peripheral Arterial Disease." Clinical
Cornerstone 4.5 (2002): 41-52. Print.

22.

Peirce, Shayn, and Thomas Skalak. "Microvascular Remodeling: A Complex
Continuum Spanning Angiogenesis to Arteriogenesis." Microcirculation 10.1
(2003): 99-111. Print.

23.

Podrid, Philip J., MD. "Pathophysiology and Clinical Presentation of Ischemic
Chest Pain." Pathophysiology and Clinical Presentation of Ischemic Chest
Pain. Ed. Juan C. Kaski, MD and Gordon M. Saperia, MD. Wolters Kluwer

26

Health, 28 Nov. 2012. Web. 10 Feb. 2013.
24.

Qiagen. "ENOS Signaling." Sample & Assay Technologies. Qiagen, n.d. Web.
27 June 2013.

25.

SAGE Labs. "Knockout Models." C57BL/6 Inbred Mouse. SAGE Labs, 2013.
Web. 04 Jan. 2013.

26.

Schaper, W. "Collateral Vessels Reduce Mortality." European Heart Journal
33.5 (2011): 564-66. Print.

27.

Stapor, P. C., and W. L. Murfee. "Spatiotemporal Distribution of
Neurovascular Alignment in Remodeling Adult Rat Mesentery Microvascular
Networks." Journal of Vascular Research 49.4 (2012): 299-308. Print.

28.

Stapor, P. C., M. S. Azimi, T. Ahson, and W. L. Murfee. "An Angiogenesis
Model for Investigating Multicellular Interactions across Intact Microvascular
Networks." American Journal of Physiology Heart and Circulatory
Physiology 2nd ser. 15.304 (2013): H235-45. Web.

29.

Tabas, Ira. "Macrophage Death and Defective Inflammation Resolution in
Atherosclerosis." Nature Reviews Immunology 10.2 (2010): 117. Print.

30.

Van Royen, Niels, Jan J. Piek, Ivo Buschmann, Imo Hoefer, Michiel Voskuil,
and Wolfgang Schaper. "Stimulation of Arteriogenesis; a New Concept for the
Treatment of Arterial Occlusive Disease." Cardiovascular Research 49.3
(2001): 543-53. Print.

31.

Zbinden, S., L. C. Clavijo, B. Kantor, H. Morsli, G. A. Cortes, J. A. Andrews,
G. J. Jang, M. S. Burnett, and S. E. Epstein. "Interanimal Variability in
Preexisting Collaterals Is a Major Factor Determining Outcome in

27

Experimental Angiogenesis Trials." AJP: Heart and Circulatory Physiology
292.4 (2006): H1891-1897. Print.

28

